Edit
Actuate Therapeutics, Inc.
http://www.actuatetherapeutics.com/Last activity: 23.02.2023
Active
Actuate Therapeutics is currently advancing a novel best-in-class GSK-3β inhibitor into the clinic for oncology and fibrotic diseases Across multiple institutions, researchers have conducted studies of 9-ING-41 with compelling results. The IND was approved in 1Q18 and a groundbreaking Phase 1/2 study is ready to initiate in 2018.
Location: United States, Texas, Fort Worth
Employees: 11-50
Total raised: $28.2M
Founded date: 2015
Investors 3
| Date | Name | Website |
| - | Tech Coast... | techcoasta... |
| - | SeedFolio | seedfolio.... |
| - | NuFund Ven... | nufund.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 13.11.2019 | Series B | $6.5M | - |
| 17.05.2019 | Series B | $21.7M | - |
Mentions in press and media 13
| Date | Title | Description |
| 23.02.2023 | Tempus Forms Multi-omics Collaboration With Actuate Therapeutics | What You Should Know: – Tempus, the $10B artificial intelligence and precision medicine company, announced their first multi-omics collaboration with Actuate Therapeutics, in which datasets of different omic groups – genomics, transcriptomi... |
| 28.10.2021 | Actuate Therapeutics Announces Primary Endpoint Met In Phase 2 Study In Pancreatic Cancer | CHICAGO and FORT WORTH, Texas (PRWEB) October 28, 2021 Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical company, today announced that their Phase 2 open-label single arm study of elraglusib (9-ING-41) plus gemcitabin... |
| 05.08.2021 | Actuate Therapeutics Announces FDA Fast Track Designation for 9-ING-41 for Treatment of Pancreatic Cancer | CHICAGO, and FORT WORTH, Texas (PRWEB) August 05, 2021 Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for... |
| 13.11.2019 | Actuate Therapeutics Closes $6.5M Series B-3 Financing Round | Actuate Therapeutics, Inc., a Chicago, IL- and Forth Worth, TX-based clinical stage biopharmaceutical company, raised an additional $6.5M in a Series B-3 financing round. This Series B-3, which brought total funding for Actuate’s Series B r... |
| 12.11.2019 | Actuate Therapeutics Completes $6.5 Million Series B-3 Financing | Actuate Therapeutics, Inc., a clinical stage biopharmaceutical company, today announced it has raised an additional $6.5M in a Series B-3 financing round. This Series B-3 was led by Bios Partners with Kairos Ventures, DEFTA Partners, and ot... |
| 20.05.2019 | Daily funding roundup - May 20th, 2019 | Daisie landed $2.5M; Arris Composites closed $10M; Health at Scale secured $16M; Modsy raised $37M Daisie: Daisie brings creators together and supports them to do amazing work. Daisie has raised $2.5 million in seed funding. The company, co... |
| 20.05.2019 | Term Sheet — Monday, May 20 | NOT JUST A TAX BREAK There’s a new opportunity fund in town. Jim Sorenson’s Catalyst, a private equity firm he helped found, is raising $150 million to invest in opportunity zones. Paid Content What you need to know about growing cyberattac... |
| 17.05.2019 | Actuate Therapeutics Completes $21.7M Series B Financing | Actuate Therapeutics, Inc., a clinical stage biopharmaceutical company, today announced it has raised $21.7 Million in a Series B financing round. The Series B is led by Kairos Ventures, with DEFTA Partners, Tech Coast Angels, and existing ... |
| 17.05.2019 | Actuate Therapeutics Completes $21.7M Series B Financing | Actuate Therapeutics, Inc., a clinical stage biopharmaceutical company, today announced it has raised $21.7 Million in a Series B financing round. The Series B is led by Kairos Ventures, with DEFTA Partners, Tech Coast Angels, and existing ... |
| 17.05.2019 | Actuate Therapeutics Closes $21.7M Series B Financing | Actuate Therapeutics, Inc., a Fort Worth, TX-based clinical stage biopharmaceutical company, raised $21.7m in Series B financing. The round was led by Kairos Ventures, with participation from DEFTA Partners, Tech Coast Angels, and existing ... |
Show more